Form EFFECT Audentes Therapeutics,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices rise 2% as US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Audentes Therapeutics (BOLD) IPO Opens Up 27%
July 20, 2016 10:36 AM EDTToday's IPO for Audentes Therapeutics (NASDAQ: BOLD) opened for trading at $19 after pricing its initial public offering of 5,000,000 shares of its common stock at a price to the public of $15.00 per share, the middle of the expected $14.00-$16.00 range.
BofA Merrill Lynch, Cowen and Company and Piper Jaffray are acting as joint... More
